MarketInOut Stock Screener Log In | Sign Up

Genolution Inc

KRX • Healthcare • Biotechnology • Quote as of 10/28/2026 15:30
Genolution Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeKRX
Market Capitalization29,285 mln
Float10.86 mln
Earnings Date08/12/2025

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-2.26
Borderline

Relative Strength

98 / 100
Top performer

Debt / Equity

0.07
Debt-free

Pre-Tax Margin

-56%
Severely loss-making

ROE

-6.55
Negative

Business Description

Genolution Inc. is a South Korean medical technology company founded in 2006 and headquartered in Seoul. It designs and produces diagnostic instruments and reagents used to extract and analyze genetic material, serving both domestic and international markets. The company also offers specialized laboratory services, including the production of synthetic RNA molecules used in genetic research and drug development.

Key Fundamentals

EPS-258
ROE-6.55
RPS555
ROIC-9.33
ROA-4.82
EBITDA, mln-3,196
EV / EBITDA-1.16
EV / EBIT-0.77
Revenue, mln10,031
EV / Revenue0.37

Quote Details

Last 1,717.00
Change 6 (0.35%)
Open 1,700.00
Volume 36,371
Turnover 62,449,008
Average Volume 45,113

Financial Ratios

Pre-Tax Profit Margin-56
Current Ratio1.29
Price / Book0.39
Price / Tangible Book0.39
Debt / Equity0.07
Price / Sales2.66

Financial Strength

Altman Z-Score1.33
Piotroski F-Score 4 / 9
Beneish M-Score-2.26
Price to Intrinsic Value0.51

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 14.39% 98 / 100   
1 Month 19.4% 97 / 100   
2 Months 26.53% 92 / 100   
6 Months -11.72% 68 / 100   
1 Year -22.31% 37 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog